Change over period: —
NSE · SHALBY
SHALBY
-48.3% from the 52-week high · +4.9% above the low
Shalby Ltd. engages in the operation of hospitals and outpatient clinics. The company is headquartered in Ahmedabad, Gujarat and currently employs 2,678 full-time employees. The company went IPO on 2017-12-15. The firm is mainly engaged in the business of setting up and managing hospitals and medical diagnostic services. Its Healthcare Services segment includes the business of setting up and managing hospitals and medical diagnostics services. Its Manufacturing segment represents the manufacturing of implants. The firm encompasses a range of specialties, which include joint replacement surgery, critical care and trauma, spine surgery, neurology, and neurosurgery, ortho-oncology, cardiology and minimally invasive cardiac surgery, sports injury, kidney transplant, liver transplant, hepato-biliary surgery, pediatrics, medical oncology and once-surgery, dental cosmetics and implantology, ophthalmology, plastic and reconstructive surgery, rheumatology, cosmetics and dermatology, homecare, bariatric surgery, gynecology, in vitro fertilization (IVF) and surrogacy counseling, homecare, among others.
The short version. SHALBY reported revenue of ₹313 crore for Sep 2026, up 9.8% from a year earlier. Net profit was ₹8 crore (up 0.0% year on year). Return on equity was 3.7% in Mar 2026. Promoter holding was 74.33% in Sep 2026, up 0.06 points over 8 quarters.
1 · The price
How has the stock traded?
SHALBY trades 48.3% below its 52-week high and 4.9% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹313 cr.
Sep 2026 net profit of ₹8 cr.
0.3 pts lower than a year earlier.
Revenue compounded at 12.2% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 313 | 331 | 287 | 272 | 285 | 296 | 265 | 276 |
| Net profit | 8 | 11 | 18 | 2 | 8 | 9 | -11 | -3 |
| Net margin % | 2.6 | 3.3 | 6.4 | 0.6 | 2.9 | 3.0 | -4.2 | -1.1 |
| EPS (₹) | 0.77 | 1.0 | 1.7 | 0.16 | 0.78 | 0.83 | -1.02 | -0.28 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1141 | 1087 | 934 | 805 | 699 | 431 | 487 | 461 |
| Net profit | 37 | 6 | 83 | 68 | 54 | 42 | 28 | 32 |
| Net margin % | 3.3 | 0.6 | 8.9 | 8.4 | 7.7 | 9.8 | 5.7 | 6.9 |
| EPS (₹) | 3.46 | 0.58 | 7.73 | 6.27 | 5.0 | 3.93 | 2.55 | 2.93 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 3.7% in Mar 2026; debt to equity is 0.54.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 3.7 | 0.6 | 8.3 | 7.3 |
| Return on capital % | 7.9 | 7.6 | 11.2 | 10.2 |
| EBITDA margin % | 14.5 | 14.4 | 20.6 | 19.2 |
| Net margin % | 3.2 | 0.6 | 8.8 | 8.2 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 12.2% | 21.6% |
| Profit CAGR | -18.0% | -2.5% |
4 · The owners
Who holds it, and are they adding?
Up 0.06 pts over 8 quarters.
Unchanged over 8 quarters.
Up 0.17 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.27 | 74.27 | 74.27 | 74.33 | 74.33 | 74.33 | 74.33 | 74.33 | +0.06 |
| FII | 4.65 | 4.54 | 5.2 | 4.64 | 4.47 | 4.36 | 4.46 | 4.65 | 0.0 |
| DII | 0.14 | 0.18 | 0.2 | 0.2 | 0.2 | 0.25 | 0.3 | 0.31 | +0.17 |
| Public | 20.25 | 20.33 | 19.64 | 20.18 | 20.35 | 20.41 | 20.26 | 20.08 | -0.17 |
Mutual fund holdings · Oct 2026
3 schemes hold this stock
3 the month before.
- Groww BSE Hospitals ETF0.15% of NAV
- Motilal Oswal BSE Healthcare ETF0.02% of NAV
- Bandhan BSE Healthcare Index Fund0.02% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for SHALBY are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Healthcare Services stocks
Quick answers
Common questions about SHALBY
What is the SHALBY share price?
SHALBY (SHALBY) last closed at ₹122.02, up 2.57% on the day. Its 52-week range is ₹113.39 to ₹230.31.
What is the market cap of SHALBY?
SHALBY has a market capitalisation of about ₹1,283 crore. Its price-to-earnings ratio is 33.4.
How are SHALBY's latest results?
SHALBY reported revenue of ₹313 crore for Sep 2026, up 9.8% from a year earlier. Net profit was ₹8 crore (up 0.0% year on year). Return on equity was 3.7% in Mar 2026. Promoter holding was 74.33% in Sep 2026, up 0.06 points over 8 quarters.
Who owns SHALBY?
As of Sep 2026, shareholding was: Promoter 74.33%, FII 4.65%, DII 0.31%, Public 20.08%.
How many mutual funds hold SHALBY?
3 mutual fund schemes held SHALBY in October 2026. That compares with 3 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 19 Sep 2024 · Final Dividend - Rs. 1.2
- 08 Aug 2023 · Final Dividend - Rs. 1.2
- 19 Sep 2022 · Final Dividend - Rs. 1
- 17 Sep 2021 · Final Dividend - Rs. 1
- 04 Sep 2020 · Final Dividend - Rs. 0.5
- 16 Aug 2019 · Final Dividend - Rs. 0.5
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.